TheraRadar

Dong-A ST

Pre-Approval PRO BETA
97
Total Trials
16
Phase 3
13
Phase 2
3
Recruiting
574
Score

Pipeline by Phase

Phase 3
16
Phase 2
13
Phase 1
55

Therapeutic Focus

Healthy Type2 Diabetes Type 2 Diabetes Mellitus Type 2 Diabetes Diabete Mellitus

Clinical Trials (97)

NCT06290349 Phase 3 ACTIVE NOT RECRUITING

Efficacy and Safety of DA5221-T When Added to Ongoing DA5221-B1 and DA5221-B2 Combination Therapy in Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control

Started: 4/1/2024

NCT06151210 Phase 3 COMPLETED

Clinical Trial to Evaluate the Efficacy and Safety of DA-5219 in Patients With Acute or Chronic Gastritis

Started: 1/31/2024

NCT05842408 Phase 3 COMPLETED

Clinical Trial of DA-5212 in Patients with Functional Dyspepsia

Started: 6/6/2023

NCT05282069 Phase 3 COMPLETED

A Study to Evaluate the Efficacy and Safety of DA-8010 in Patients With Overactive Bladder

Started: 5/12/2022

NCT04785326 Phase 3 COMPLETED

Efficacy, Safety, and Immunogenicity of Subcutaneous DMB-3115 Versus Stelara® in Patients With Moderate to Severe Chronic Plaque Psoriasis

Started: 4/28/2021

NCT04356742 Phase 3 COMPLETED

Efficacy and Safety of Dapagliflozin When Added to Ongoing Metformin and Evogliptin Combination Therapy in Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control

Started: 5/26/2020

NCT04170998 Phase 3 COMPLETED

Efficacy and Safety of Evogliptin When Added to Ongoing Metformin and Dapagliflozin Combination Therapy in Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control

Started: 1/2/2020

NCT02967939 Phase 3 COMPLETED

Efficacy and Safety of DA-2802 in Chronic Hepatitis B Patients

Started: 3/28/2017

NCT03343145 Phase 3 COMPLETED

A Study to Evaluate the Efficacy, Safety and Immunogenicity of Leucostim® Versus Neupogen® in Breast Cancer Patients

Started: 1/12/2017

NCT02770157 Phase 3 COMPLETED

Efficacy and Safety of DA-3002 in Short Children Borns SGA.

Started: 2/26/2016

NCT01813630 Phase 3 COMPLETED

A Clinical Study to Assess the Efficacy and Safety of DA-3002

Started: 2/1/2013

NCT01786902 Phase 3 COMPLETED

Efficacy and Safety of DA-3002 in Children With Idiopathic Short Stature

Started: 2/1/2012

NCT02946541 Phase 3 COMPLETED

A Clinical Trial to Investigate the Efficacy and Safety of Evogliptin

Started: 7/1/2013

NCT02949193 Phase 3 COMPLETED

Efficacy and Safety of Evogliptin add-on to Metformin in Patients With type2 Diabetes

Started: 5/1/2013

NCT01674855 Phase 3 COMPLETED

Phase III Study of DA-3031(PEG-G-CSF) in Chemotherapy-induced Neutropenia

Started: 2/1/2012

NCT07239440 Phase 2 NOT YET RECRUITING

Clinical Trial to Evaluate the Efficacy and Safety of DA-2811 When Added to Ongoing BT-1 and BT-2 Combination Therapy in Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control

Started: 11/1/2025

NCT04055883 Phase 2 COMPLETED

Clinical Study to Evaluate Efficacy and Safety of DA-1229 in Patients With CAVD

Started: 8/26/2019

NCT03189563 Phase 2 COMPLETED

Safety and Efficacy of DA-9805 for Parkinson's Disease

Started: 2/6/2018

NCT02554240 Phase 2 COMPLETED

Study to Evaluate the Efficacy and Safety of Intra-articular DA-5202 in Patients With Osteoarthritis of the Knee

Started: 12/23/2014

NCT03566134 Phase 2 COMPLETED

A Therapeutic Exploratory Clinical Study of DA-8010 in Patients With Overactive Bladder

Started: 7/10/2018

NCT02365701 Phase 2 COMPLETED

Study of Motilitone to Treat Functional Dyspepsia

Started: 6/1/2015

NCT01813799 Phase 2 COMPLETED

Study of DA-9801 to Treat Diabetic Neuropathic Pain

Started: 11/1/2011

NCT01553721 Phase 2 COMPLETED

Efficacy and Safety Study of Udenafil in Patient With Pulmonary Arterial Hypertension(PAH)

Started: 8/1/2011

NCT02304198 Phase 2 COMPLETED

Clinical Trial to Evaluate the Long-term Safety of Udenafil in Patient With PAH

Started: 4/1/2014

NCT01670357 Phase 2 COMPLETED

Phase II Study of DA-6034 Eye Drops in Dry Eye Syndrome

Started: 4/1/2012

NCT01923545 Phase 2 COMPLETED

Phase II Study of DA-3031(PEG-G-CSF) in Chemotherapy-induced Neutropenia

Started: 7/1/2010

NCT07007520 Phase 1 RECRUITING

A Study to Evaluate the Food Effect on the Pharmacokinetics of DA-5223 in Healthy Adult Subjects

Started: 11/1/2025

NCT06293651 Phase 1 RECRUITING

Clinical Trial to Investigate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of DA-4505 as a Single Agent and in Combination With Pembrolizumab in Adult Patients With Locally Advanced or Metastatic Solid Tumors

Started: 4/18/2024

NCT07342062 Phase 1 COMPLETED

Pharmacokinetics and Safety Profiles of DA-1229_01 in Healthy Subjects at Fed State

Started: 1/6/2026

NCT07513649 Phase 1 NOT YET RECRUITING

A Study to Evaluate the Bioequivalence of DA-5230 Compared to DA-5230-R

Started: 4/1/2026

NCT07297940 Phase 1 COMPLETED

Pharmacokinetics and Safety Profiles of DA-1229_01 in Healthy Subjects at Fasting State

Started: 12/14/2025

NCT07481357 Phase 1 NOT YET RECRUITING

A First-In-Human Phase I/IIa Study to Evaluate DA 3501 in Patients With Advanced Gastric or Gastro-esophageal Junction Adenocarcinoma and Pancreatic Ductal Adenocarcinoma

Started: 2/1/2026

NCT07239453 Phase 1 ENROLLING BY INVITATION

Clinical Trial of Comparing DA-2902 and DA-2902-R in Healthy Adult Subjects

Started: 10/20/2025

NCT07046715 Phase 1 COMPLETED

Clinical Trial Comparing Single-administration of DA-5222 and Co-administration of DA-5222-R1, DA-5222-R2 and DA-5222-R3 in Healthy Adult Subjects in Fed State

Started: 7/7/2025

NCT07027982 Phase 1 COMPLETED

A Study to Evaluate the Pharmacokinetics and Safety of Diluted vs. Undiluted Intravenous DA-5217 in Healthy Adult Subjects

Started: 7/16/2025

NCT07007533 Phase 1 COMPLETED

A Study to Compare and Evaluate the Safety, Tolerability and Pharmacokinetics Between DA-5223 and DA-5223-R in Healthy Adult Subjects

Started: 7/4/2025

NCT06993181 Phase 1 NOT YET RECRUITING

Clinical Trial of Comparing DA-5222 Single-administration and Co-administration of DA-5222-R1, DA-5222-R2 and DA-5222-R3 in Healthy Adult Subjects

Started: 6/1/2025

NCT06993168 Phase 1 NOT YET RECRUITING

To Evaluate Effect of Food of DA-5222 in Healthy Adult Subjects

Started: 5/21/2025

NCT06616883 Phase 1 NOT YET RECRUITING

Pharmacokinetics and Safety Profiles After Administration of DA-5221_01 and Co-administration of 5221_01-R1 and DA-5221_01-R2 in Healthy Adult Volunteers

Started: 9/30/2024

NCT05812417 Phase 1 COMPLETED

A Study to Evaluate the Effects of Renal Function on Pharmacokinetics and Safety of DA-8010

Started: 5/2/2023

NCT06391827 Phase 1 NOT YET RECRUITING

A Study to Evaluate Safety, Tolerability, and PK of DA-7503 in Healthy Adult and Elderly Participants

Started: 5/7/2024

NCT05991401 Phase 1 COMPLETED

Evaluate the Effect of Clarithromycin/Rifampicin on the Pharmacokinetics of DA-8010 in Healthy Adults

Started: 8/18/2023

NCT05992428 Phase 1 COMPLETED

Drug Interactions When DA-8010 is Co-administered With Paroxetine or Mirabegron in Healthy Adults

Started: 8/22/2023

NCT05127746 Phase 1 COMPLETED

Phase 1 Clinical Trial of DA-5207 in Healthy Adults

Started: 11/25/2021

NCT04906109 Phase 1 COMPLETED

Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of DA-2803 in Healthy Subjects

Started: 7/12/2021

NCT05106205 Phase 1 COMPLETED

Phamacokinetics and Safety Profiles of DA-5213 10mg in Healthy Subjects

Started: 12/21/2021

NCT05132049 Phase 1 COMPLETED

Pharmacokinetics and Safety Profiles After Administration of DA-5211 and Co-administration of DA-5211-R1 and DA-5211-R2 in Healthy Adult Volunteers

Started: 12/18/2021

NCT05108571 Phase 1 COMPLETED

Phamacokinetics and Safety Profiles of DA-5210 10/1000mg in Healthy Subjects at Fasting State

Started: 10/28/2021

NCT04938752 Phase 1 COMPLETED

Pharmacokinetics and Safety/Tolerability Profiles of DA-2811 in Healthy Subjects (DA-2811)

Started: 7/8/2021

NCT05098262 Phase 1 COMPLETED

Phamacokinetics and Safety Profiles of DA-5210 10/500mg in Healthy Subjects at Fasting State

Started: 10/31/2021

NCT05098886 Phase 1 COMPLETED

Phamacokinetics and Safety Profiles of DA-5210 10/1000mg in Healthy Subjects at Fed State

Started: 11/7/2021

NCT05098275 Phase 1 COMPLETED

Phamacokinetics and Safety Profiles of DA-5210 10/500mg in Healthy Subjects at Fed State

Started: 10/26/2021

NCT04195919 Phase 1 COMPLETED

The Pharmacokinetics/Pharmacodynamics and Safety/Tolerability of Evogliptin in Hemodialysis Patients

Started: 7/10/2020

NCT02241200 Phase 1 COMPLETED

A Study in Healthy Volunteers to Compare the Profiles of DA-3880 and EU Sourced ARANESP® (Amgen)

Started: 8/18/2014

NCT04686825 Phase 1 COMPLETED

The Food Effect on Pharmacokinetics of DA-8010 After a Single Administration of DA-8010 2.5 mg or 5 mg in Healthy Subjects

Started: 1/13/2021

NCT01633723 Phase 1 COMPLETED

Phase I Clinical Trial of DA-6886 in Healthy Male Subjects

Started: 8/1/2012

NCT04013477 Phase 1 COMPLETED

Single-ascending Dose Phase 1 Clinical Trial to Evaluate the Safety and PK of DA-5207 TDS in Healthy Adults

Started: 6/18/2019

NCT04473417 Phase 1 COMPLETED

Pharmacokinetics and Safety/Tolerability Profiles of DA-2811 in Healthy Subjects

Started: 8/4/2020

NCT03646721 Phase 1 COMPLETED

A Study to Evaluate the Safety, Tolerability, PK and PD of DA-1241 in Healthy Male Subjects and Subjects With T2DM

Started: 8/29/2018

NCT04671316 Phase 1 COMPLETED

Bioequivalence Study Between "DA-5209 Tab" and "Lixiana Tab"

Started: 11/23/2020

NCT03939143 Phase 1 COMPLETED

A Study to Investigate the Bioequivalence Test of DA-1229_01(A) at Fasting State

Started: 2/7/2019

NCT03944200 Phase 1 COMPLETED

A Study to Investigate the Bioequivalence Test of DA-1229_01(A) at Fed State

Started: 2/7/2019

NCT02097043 Phase 1 COMPLETED

Phase I Clinical Study to Investigate the Pharmacokinetics and Safety/Tolerability of DA-7218 in Healthy Male Volunteers

Started: 5/1/2014

NCT03766724 Phase 1 COMPLETED

Pharmacokinetic and Pharmacodynamic Drug-Drug Interaction of Evogliptin and Empagliflozin or Dapagliflozin in Healthy Male Adults

Started: 11/22/2018

NCT02963389 Phase 1 COMPLETED

A Study to Evaluate Safety, Tolerability, and Pharmacokinetics/Pharmacodynamics of Tripegfilgrastim in Pediatric Solid Tumor/Lymphoma Patients

Started: 10/4/2016

NCT02824380 Phase 1 COMPLETED

Pharmacokinetics/ Pharmacodynamics and Safety of DA-4001 in Healthy Male Subjects With Androgenic Alopecia

Started: 7/1/2016

NCT02754219 Phase 1 COMPLETED

Pharmacokinetics and Safety of Evogliptin in Subjects With Hepatic Dysfunction

Started: 9/22/2016

NCT03061981 Phase 1 COMPLETED

A Study To Evaluate The Safety,Tolerability, PK and PD Of DA-1241 In Healthy Male Subjects

Started: 3/29/2017

NCT02753803 Phase 1 COMPLETED

Pharmacokinetic/Pharmacodynamic Drug-drug Interaction of Evogliptin 5 mg and Pioglitazone 30 mg

Started: 7/27/2016

NCT02954822 Phase 1 COMPLETED

Pharmacokinetic/Pharmacodynamic Drug-drug Interaction of Evogliptin 5mg and Glimepiride 4mg

Started: 11/14/2016

NCT03200496 Phase 1 COMPLETED

Pharmacokinetics and Safety/Tolerability Profiles of DA-5206 Versus Talion® Under Fasting and Fed States in Healthy Male Subjects

Started: 5/29/2017

NCT02557594 Phase 1 COMPLETED

Clinical Trial to Assess the Safety and Pharmacokinetics of DA-2802 319mg and Viread 300mg in Healthy Male Volunteers

Started: 10/6/2015

NCT02725086 Phase 1 COMPLETED

Evaluation of Pharmacokinetic/Pharmacodynamic Properties and Safety of Leucostim® Compared to Neupogen® in Healthy Adult Volunteers

Started: 2/1/2016

NCT02214693 Phase 1 COMPLETED

PK//PD/Tolerability Study of DA-1229(Evogliptin) in Renal Impaired Patients

Started: 7/1/2014

NCT02375139 Phase 1 COMPLETED

A Clinical Trial to Investigate Safety/Tolerability and Pharmacokinetics of DA-1229_01(Evogliptin/Metformin XR 2.5/500 mg x 2 Tablets) Compared to Co-administration of Evogliptin 5 mg and Metformin XR 1000 mg in Healthy Male Volunteers

Started: 4/1/2015

NCT02280603 Phase 1 COMPLETED

Clinical Trial to Explore the Efficacy and Safety of DA-4001 After Topical Application

Started: 1/1/2014

NCT02167061 Phase 1 COMPLETED

A Clinical Trial to Investigate Safety/Tolerability and Pharmacokinetics of DA-1229_01 Compared to Co-administration of Evogliptin 5 mg and Metformin XR 1000 mg, and to Evaluate the Effect of Food on the Pharmacokinetics of DA-1229_01 in Healthy Male Volunteers

Started: 7/1/2014

NCT00967772 Phase 1 COMPLETED

The Safety/Tolerability and Pharmacokinetics (PKs) of Naftopidil in Korean Healthy Male Volunteers

Started: 9/1/2009

NCT01526122 Phase 1 COMPLETED

Pharmacokinetics & Safety Study of Clopidogrel 75mg and Aspirin 100mg Coadministration

Started: 9/1/2011

NCT01162954 Phase 1 COMPLETED

Phase I Study to Evaluate the Tolerability of Eye Drop DA-6034 in Healthy Volunteers

Started: 9/1/2008

NCT01751919 Phase 1 COMPLETED

A Clinical Trial to Compare the Pharmacokinetics of Imatinib Mesylate Tablet 400mg (1 Tablet) and Glivec Film-coated Tablet 100mg (4 Tablets)(Phase I)

Started: 5/1/2012

NCT07229534 Phase 4 NOT YET RECRUITING

Clinical Trial to Evaluate the Efficacy and Safety of DA-5218 in Patients With Type 2 Diabetes

Started: 11/1/2025

NCT05630768 Phase 4 COMPLETED

Efficacy and Safety of Actonel® After Denosumab Discontinuation in Postmenopausal Osteoporosis Women

Started: 1/3/2023

NCT05743907 Phase 4 COMPLETED

Clinical Trial to Evaluate the Efficacy and Safety of DA-2811 When Added to Ongoing Metformin Monotherapy in Patients with Type 2 Diabetes Who Have Inadequate Glycemic Control

Started: 4/25/2023

NCT05957380 Phase 4 COMPLETED

Clinical Study to Evaluate the Efficacy and Safety of DA-2803 in Chronic Hepatitis B Patients

Started: 3/20/2023

NCT03910361 Phase 4 COMPLETED

Efficacy and Safety of Evoglitin in Patients With Type 2 Diabetes and Non-alcoholic Fatty Liver Diseases

Started: 4/12/2019

NCT03280927 Phase 4 COMPLETED

Phase IV Clinical Trial to Evaluate the Efficacy and Safety of Jublia® in Mild to Moderate Toenail Onychomycosis

Started: 11/10/2017

NCT01817556 Phase 4 COMPLETED

A Study to Evaluate the Efficacy and of Stillen Tab. and to Demonstrate the Non-inferiority of Stillen Tab.

Started: 10/1/2012

NCT02955706 Phase 4 COMPLETED

Assessment the Efficacy of Acetyl-L-carnitine in Patient With Alzheimer's Disease

Started: 4/1/2016

NCT02780323 Phase 4 COMPLETED

Study to Compare the Efficacy and Safety of CELBESTA® and CELEBREX® in Patients With Rheumatoid Arthritis

Started: 11/2/2015

NCT02974504 Phase 4 COMPLETED

Phase IV Clinical Trial to Investigate the Effect on Blood Glucose of Evogliptin in Patients With Type 2 Diabetes(EVERGREEN)

Started: 9/1/2016

NCT02204722 Phase 4 TERMINATED

A Study to Evaluate Efficacy and Safety of Glinib in Newly Diagnosed CML Patients

Started: 10/13/2014

NCT01913431 Phase 4 COMPLETED

Baracle Tab. ® Versus Baraclude Tab.® for Patients With HBeAg Chronic Hepatitis B

Started: 9/12/2013

NCT02433119 Phase 4 COMPLETED

The Efficacy and Safety of OROSARTAN® Versus CODIOVAN® in Patients With Essential Hypertension Uncontrolled With Monotherapy

Started: 3/16/2015

NCT02280590 Phase 4 COMPLETED

Comparison of the Efficacy and Safety of Cresnon® and Crestor® in Patients With Hyperlipidemia

Started: 9/1/2014

NCT01817465 Phase 4 COMPLETED

A Study to Demonstrate the Efficacy and Safety of Motilitone®

Started: 8/1/2012

NCT01912066 Phase 4 COMPLETED

A Multicenter, Double Blinded, Randomized, Parallel Assignment Study to Demonstrate the Efficacy of DA9601

Started: 9/1/2012

Drug Candidates

DA-1229_01 DA-1229_01-R DA-5230 DA-5230-R DA-3501 DA-2811 DA-2811-C DA-2902 DA-2902-R DA5221-T1
Activity Status: Active
Last Trial Started: 4/1/2026
Last Trial Ended: 2/14/2026
Trials (12 months): 13
Completed Trials: 84
Data sourced from ClinicalTrials.gov. This company has no FDA-approved drugs.